Accuray International

Accuray Incorporated (Nasdaq: ARAY) invents, manufactures and supports a complete portfolio of radiation therapy and radiosurgery platforms for treating multiple forms of cancer. Our team works passionately to create a future without the fear, pain or human suffering of cancer. With over 800 systems installed worldwide, our leading edge technologies - the Cyberknife®, TomoTherapy® and Radixact™ Systems - put the emphasis on patient-focused care. Our offerings range from high-precision radiosurgery for early-stage and localized disease to 3D image-guided, intensity-modulated-radiation therapy for more advanced disease throughout the body.